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Abstract
When a physiological (exercise) stress echo is scheduled, interest focuses on wall motion segmental contraction
abnormalities to diagnose ischemic response to stress, and on left ventricular ejection fraction to assess contractile
reserve. Echocardiographic evaluation of volumes (plus standard assessment of heart rate and blood pressure) is
ideally suited for the quantitative and accurate calculation of a set of parameters allowing a complete characteriza-
tion of cardiovascular hemodynamics (including cardiac output and systemic vascular resistance), left ventricular
elastance (mirroring left ventricular contractility, theoretically independent of preload and afterload changes heavily
affecting the ejection fraction), arterial elastance, ventricular arterial coupling (a central determinant of net cardio-
vascular performance in normal and pathological conditions), and diastolic function (through the diastolic mean
filling rate). All these parameters were previously inaccessible, inaccurate or labor-intensive and now become, at
least in principle, available in the stress echocardiography laboratory since all of them need an accurate estimation
of left ventricular volumes and stroke volume, easily derived from 3 D echo.
Aims of this paper are: 1) to propose a simple method to assess a set of parameters allowing a complete charac-
terization of cardiovascular hemodynamics in the stress echo lab, from basic measurements to calculations 2) to
propose a simple, web-based software program, to learn and training calculations as a phantom of the everyday
activity in the busy stress echo lab 3) to show examples of software testing in a way that proves its value.
The informatics infrastructure is available on the web, linking to http://cctrainer.ifc.cnr.it
Introduction
Recent technological development and engineering
refinements have allowed the application of real-time
three-dimensional (RT3D) echocardiography in the rou-
tine clinical setting [1]. Because full-volume datasets
obtained with RT3 D echocardiography incorporate
information on the entire left ventricle in four volu-
metric datasets, RT3 D echocardiography has the poten-
tial to overcome many of the limitations encountered
with two-dimensional echocardiography, mostly by elim-
inating the need for geometric modelling and the errors
caused by the use of foreshortened views [2]. Three-
dimensional (3D) volumetric imaging has potential
advantages in stress echocardiography, including the
ability to provides an accurate assessment of stroke
volume, allowing derivation of a set of hemodynamic
measures usually difficult or impossible to obtain with
two-dimensional (2D) echocardiography [3-6]. However
calculations are time-consuming and difficult to plan in
the busy stress echo lab, and generally cardiologists are
not well-trained in these calculations. Therefore we pre-
sent a WEB based software program for calculation
training in the 3 D stress echo lab. The “algorithms”,
“testing” and “implementation” of this new computa-
tional method will be described. The informatics infra-
structure is available on the web, linking to http://
cctrainer.ifc.cnr.it.
Once the electronic rest and stress data set is filled,
the CCtrainer program will show that echo-measured
volumes (plus standard assessment of heart rate and
blood pressure) allow a complete characterization of
cardiovascular hemodynamics (including cardiac output
and systemic vascular resistance), left ventricular ela-
stance (Figure 1, Figure 2, Figure 3) arterial elastance
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(essential for characterizing the distal impedance of the
arterial system downstream of the aortic valve) (Figure
4, Figure 5), ventricular arterial coupling, a central
determinant of net cardiovascular performance in nor-
mal and pathological conditions (Figure 6), and diastolic
function [7-11].
Methods
Web-based system architecture
A computerized web-based system has been developed
for data transfer, analysis and report phases. All the
computer clients connect to the server merely by using
a common web browser, without needing to install any
specific software. Data and reports are anonymous, so
secure protocols are not required.
Communication phases
The informatics infrastructure is available on the web,
linking to http://cctrainer.ifc.cnr.it.
When operating for the first time, a user need to get his/
her user - password clicking on the “new user” button.
The CCTRAINER calculation program is completely free
for use during the first month of operations. Algorithms
and data sheets can be freely downloaded. Values and
indexes are obtained automatically by software processing.
After the first month, to continue using the program each
user must be registered by the server administrator
who assigns him/her an account and an exclusive
memory area on the database server. A user license
could be purchased by bank transfer to the CNR. Page
1 of the WEB site http://cctrainer.ifc.cnr.it. gives time
and modalities of extending the time of program use.
Only then can the user access his/her data in pro-
tected and reserved mode.
Parameters to be filled in on the “rest and peak stress”
electronic sheet
In each training example the age, height, and weight will
be filled in and body mass index and body surface area
will be calculated. A complete data set to fill in the elec-
tronic sheet is shown in Table 1 and listed below:
Heart rate (bpm)
Systolic Blood Pressure (SBP, mmHg) and Diastolic
Blood Pressure (DBP, mmHg) The blood pressure
recording is made using a sphygmomanometer and the
diaphragm of a standard stethoscope. The auscultatory
pressure is obtained by inflating the cuff to a level
approximately 30 mm Hg above the peak level of systo-
lic blood pressure and evaluating Korotkoff’s sounds.
The systolic blood pressure is recorded as the point
where the first tapping sound occurs for 2 consecutive
beats. The right and left brachial arterial systolic blood
Figure 1 Stress echo lab: contractility me too? Blood pressure analysis. One investigator records all blood pressures at rest and during exercise
during the study. The blood pressure recording is made using a manometer sphygmomanometer and the diaphragm of a standard stethoscope.
Echocardiography is performed using 3-D or conventional 2-D echocardiography and left ventricular end-systolic volume is measured. The
contractility is determined at each stress step as the ratio of the systolic pressure (cuff sphygmomanometer)/end-systolic volume index (end-
systolic volume/body surface area). Modified from Bombardini T. Myocardial contractility in the echo lab: molecular, cellular and
pathophysiological basis. Cardiovascular ultrasound 2005, 3:27 [11].
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pressures are compared and discrepancies greater than
5 mm Hg are reported [12].
LV End-Diastolic Volume (EDV, mL) is measured
from the apical view by an experienced observer using 3
D echo or by apical 4- and 2-chamber views using
(Simpson’s rule) 2 D echo. The frame captured at the
R-wave in ECG in triggered software is considered to be
the end-diastolic frame [13,14]; or the end-diastolic
volume is obtained from the LV volume curves as the
maximum value.
LV End-Systolic Volume (ESV mL) is measured from
the apical view by an experienced observer using 3 D
echo or by apical 4- and 2-chamber views using (Simp-
son’s rule) 2 D echo. The frame captured at the smallest
Figure 2 Contractility changes with heart rate changes. The force-frequency relationship is defined up-sloping (upper panel) when the peak
exercise SP/ESV index is higher than baseline and intermediate stress values; flat or negative (lower panel), when the peak exercise systolic
pressure/end-systolic volume index is equal to or lower than baseline stress values. The critical heart rate (or optimum stimulation frequency) is
defined as the heart rate at which systolic pressure/end-systolic volume index reaches the maximum value during progressive increase in heart
rate.
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Figure 3 Preload, afterload, heart rate: the dark side of the force. When a stress echo is scheduled, interest is focused on wall motion
segmental contraction abnormality to diagnose ischemic response to stress and on LVEF to assess contractile reserve. However, ejection fraction
is a very gross index of left ventricular performance. It is affected by pre-load and after-load changes and heart rate. Left panel. The graph shows
how two additional pressure-volume loops appear with an acute increase in afterload or preload. Contractility is quantified by the end-systolic
pressure volume relation slope: the Ees (end systolic elastance). Right panel. Increased contractility is reflected in higher myocardial fiber
shortening velocity, with a more highly developed tension peak and a steeper pressure rise, when preload, after load, and heart rate are
constant: the Ees (end systolic elastance) moves upward and to the left. Lower panel. Force-frequency relation or Bowditch treppe. In the healthy
heart, a frequency increase up to 180 beats per minute provides for faster systolic calcium SR release (increased contractility or developed force)
and for faster diastolic SR calcium reuptake (positive lusitropic effect).
Figure 4 Arterial elastance. In the cartoon (left panel) a compliant and no resistive young hungry snake eats a big sheep easily. In the
cardiovascular system the hydraulic load, namely effective arterial elastance, is described by the formula: End Systolic Pressure/Stroke Volume/
Body Surface Area (right panel). Intuitively a well compliant and no resistive vascular system easily accomplish a big stroke volume without great
increase of systemic pressure: steady End Systolic Pressure/Stroke Volume ratio; “low-good” arterial elastance. Intuitively a bad compliant and
resistive vascular system difficultly accomplish the stroke volume with greater increase of systemic pressure: increased End Systolic Pressure/
Stroke Volume ratio; “high-bad” arterial elastance. On the basis of the windkessel model, effective arterial elastance Ea is a steady-state arterial
parameter that incorporates peripheral resistance, characteristic impedance, and total lumped arterial compliance and that also incorporates
systolic and diastolic time intervals. Since the pioneer work of Kelly et al. [38], which confirmed the clinical applicability of this concept in
humans, effective arterial elastance Ea has been used to quantify arterial load during aging, in hypertensive patients, and in various forms of
cardiac disease. Ees = left ventricular end-systolic elastance, ESV = end-systolic volume, ESP = end-systolic pressure, EDV = end-diastolic volume.
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left ventricular cavity is considered to be the end-systo-
lic frame [13,14].
Pulsed Doppler mitral diastolic E (cm/sec) Pulsed Dop-
pler mitral diastolic inflow (E, cm/sec) is recorded using
pulse-wave Doppler, with the sample volume placed at
the tips of the mitral leaflets on the apical four-chamber
view. Mitral inflow velocity measurements are recorded
at end-expiration during ambient respiration [15].
Tissue Doppler mitral annular tissue velocity e’ (cm/
sec) Mitral annular tissue velocity (e’, cm/sec) is
recorded using pulse-wave Doppler in the apical four-
chamber view. It is recommended to acquire and mea-
sure tissue Doppler signals at least at the septal and
lateral sides of the mitral annulus and their average,
given the influence of regional function on these veloci-
ties and time intervals. Mitral annular tissue velocity
measurements are recorded at end-expiration during
ambient respiration [15].
Diastolic time (M-Mode or Precordial Sensor, msec)
Prior work concerning diastolic duration (diastolic time)
has been motivated primarily by consideration of diastolic
myocardial perfusion time rather than the duration of
mechanical events, and has been used to assess the heart
rate-dependent effects of pharmacological agents [16,17].
Recent studies utilizing both the exercise radionu-
clide angiography time activity curve [18] or Doppler
echocardiography [19,20] assessed that cardiac perfor-
mance may be characterized in terms of the relative
duration of diastole and systole. Cardiac cycle
abnormalities of patients with heart failure are charac-
terized by a prolongation of left ventricular systole
and an abnormal shortening of left ventricular diastole
[21]. A practical approach is to calculate cardiological
diastolic and systolic time in the echo lab (Figure 7)
(Table 2).
A cutaneous operator independent force sensor, based
on first heart and second heart sound vibrations ampli-
tude recording [22,23], may be utilized to automatically
quantify cardiological systole and cardiological diastole
duration [24] (Table 2) (Figure 8). Simultaneous calcula-
tion of stroke volume allows quantifying diastolic filling
rate and its changes with stress.
Diastolic time/systolic time ratio The diastolic/systo-
lic time ratio is expressed as a dimensionless ratio (dia-
stolic/systolic, normal value > 1). Reversal of the
normal diastolic/systolic ratio may compromise cardiac
filling and function. The diastolic/systolic mismatch is
accentuated during exercise and has the potential to
impair the cardiac reserve in these patients by restrict-
ing ventricular filling and coronary perfusion time [25]
(Table 3).
Tricuspid Regurgitation Peak Gradient (TRPG,
mmHg) Tricuspid regurgitation velocity is usually
obtained with continuous wave Doppler from the right
ventricular inflow or the apical four-chamber view posi-
tion. Tricuspid regurgitation velocity reflects the
Figure 5 The steady (Systemic Vascular Resistance) and the pulsatile (Systemic Arterial Compliance) components of Arterial Elastance.
In the cartoon (left panel) the skinny snake is a thin pipe with high strength, the snake stretched by food is a low resistance conduit. In the
cartoon (middle panel) the compliant snake easily dilates itself and pushes the food at pulsatile waves. In the cartoon (right panel) the blind zoo
guardian unsuccessfully try to use the snake tail (extremely resistive and no compliant) as a water conduct. Increased systemic vascular resistance
and decreased total arterial compliance both contribute to the high arterial load in hypertensive patients.
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pressure difference during systole between the right ven-
tricle and the right atrium, that is:
Transtricuspid pressure gradient Tricuspid regurgitation   = 4 *  velocity2
Normal resting values are usually defined as a peak
tricuspid regurgitation velocity of < 2.8 to 2.9 m/s. This
value may increase with age and increasing body surface
area and this should be considered when estimations are
at the upper limits of normal. Further evaluation of
patients with dyspnea with estimated right ventricular
systolic pressure > 40 mmHg is recommended [26].
Right Atrial Pressure (RAP, mmHg) is estimated
from the inferior vena cava diameter adjacent to the
right atrium in the subcostal view [27] (Table 4). As
right atrium pressure increases, this is transmitted to
Figure 6 Ventricular-arterial coupling. In the cartoon, arterial elastance is the “mouth” of the whale. Big mouth means low arterial elastance (no
resistive and well compliant), able to easily accommodate large stroke volume energetically ejected; small fish mouth means higher arterial
elastance (highly resistive and no compliant), able to accommodate only small stroke volume (low contractile-energy launched). Understanding the
performance of the left ventricle (LV) requires not only examining the properties of the LV itself, but also investigating the modulating effects of the
arterial system on left ventricular performance. Interaction of the LV with the arterial system, termed ventricular-arterial coupling, is a central
determinant of cardiovascular performance and cardiac energetics. Ventricular arterial coupling is indexed by the ratio of left ventricular systolic
elastance index (systolic pressure/end-systolic volume) to arterial elastance (Ea, ratio of end-systolic pressure by stroke volume). Although in the
resting state ventricular-arterial coupling is maintained in a range that maximizes the efficiency of the heart, when the system is stressed, energy
efficiency is sacrificed in favor of cardiac efficiency, manifested by an increase in the coupling index (i.e., a greater relative increase in ventricular
contractility than arterial load). Ventricular arterial coupling is normally set toward higher left ventricular work efficiency, whereas in patients with
moderate cardiac dysfunction, ventricular and arterial properties are matched to maximize stroke work at the expense of work efficiency.
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the inferior vena cava, resulting in reduced collapse
with inspiration and inferior vena cava dilatation. A
inferior vena cava diameter < 2.1 cm that collapses >
50% with a sniff suggests a normal right atrium pres-
sure of 3 mm Hg (range, 0-5 mm Hg), whereas an
inferior vena cava diameter > 2.1 cm that collapses <
50% with a sniff suggests a high right atrium pressure
of 15 mm Hg (range, 10-20 mm Hg). In indeterminate
cases in which the inferior vena cava diameter and col-
lapse do not fit this paradigm (inferior vena cava dia-
meter > 2.1 cm that collapses > 50% with a sniff; or
inferior vena cava diameter < 2.1 cm that collapses >
50% with a sniff) an intermediate value of 8 mm Hg
(range, 5-10 mm Hg) may be used, or, preferably, sec-
ondary indices of elevated right atrium pressure should
be integrated [27].
Pulmonary Artery end-diastolic velocity (m/sec) The
end-diastolic velocity of pulmonary regurgitation reflects
the end-diastolic pressure gradient between the pulmon-
ary artery and the right ventricle. Normally, the pulmon-
ary regurgitation end-diastolic pressure gradient is less
than 5 mmHg. An increase in this pressure gradient (>
5 mmHg) has been found to correlate with systolic dys-
function, diastolic dysfunction, increased brain natriure-
tic peptide, and decreased functional status [28].
Peak pulmonary regurgitation velocity (m/sec) The
peak early diastolic pulmonary regurgitation velocity is
useful in estimating mean pulmonary artery pressure.
The peak diastolic pressure gradient between the
pulmonary artery and the right ventricle approximates
mean pulmonary artery pressure [29].
Time-Velocity Integral (TVI, cm) of Right Ventricular
Outflow Tract flow (RVOT) The right ventricular out-
flow tract time-velocity integral is obtained by placing a
1- to 2-mm pulsed wave Doppler sample volume in the
proximal right ventricular outflow tract just within the
pulmonary valve when imaged from the parasternal
short-axis view [30].
An example of the web downloadable “rest and stress
parameters” electronic sheet is shown in Figure 9.
Results
The rest and stress data calculator algorithms
A complete data set with software automatically calcu-
lated parameters, method of calculation and measure
units is shown in Table 5. An example of the “calculated
results” electronic sheet is shown in Figure 10. The spe-
cific algorithms are listed below:
Body Surface Area (BSA, m2)
BSA = (kg0.5378)(cm0.3964)
BSA = Sq. Root {(Kg.)*(Cm.)/(3600)}
Normal values 1.5-3.5 m2 (adults)
BSA often used to standardize various physiologic
measurements or dosing regimens
Stroke Volume (SV, mL)
The stroke volume is calculated as:
Stroke volume (SV, mL) = End-diastolic volume -
End-systolic volume
Table 1 Rest and peak stress data set
Values Method Measure unit
Height Standard cm
Weight Standard kg
Heart rate ECG bpm
“Left” heart
LV ESV 3 D echo or 2 D echo (Simpson rule) mL
LV EDV 3 D echo or 2 D echo (Simpson rule) mL
SBP Sphygmomanometer or Tonometer mmHg
DBP Sphygmomanometer or Tonometer mmHg
Mitral E Doppler cm/sec
Mitral TDI e´ Tissue Doppler cm/sec
Diastolic time M-Mode or Precordial Sensor msec
Diastolic time/systolic time ratio M-Mode or Sensor ratio
“right"heart
Peak TR jet velocity Doppler m/sec
TR peak gradient Doppler mmHg
Right Atrium Pressure (RA pressure) 2 D echo - vena cava respiratory motion mmHg
Pulmonary artery end-diastolic velocity Doppler m/sec
Early pulmonary regurgitation velocity Doppler m/sec
Right Ventricular Outflow Tract (RVOT) Time-Velocity Integral (TVI) Doppler cm
SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; TR = Tricuspid Regurgitation; LV EDV = Left Ventricular End-Diastolic Volume; LV ESV = Left
Ventricular End-Systolic Volume; RV = Right Ventricular.
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(normal values 60-100 ml/beat)
Stroke Volume is indexed by dividing it by body sur-
face area [31].
Stroke volume index (SVI, mL/m2) = Stroke volume/
BSA
Cardiac Output (CO, L/min)
The Cardiac Output is calculated as:
Cardiac output = Heart rate * Stroke volume
Normal Cardiac Output is approx. 4-6 L/min
The relative contribution of end-systolic vs end-diasto-
lic LV volume changes to increase stroke volume during
stress can be calculated [32,33].
Cardiac Index (CI, L/min/m2)
Cardiac Index standardizes Cardiac Output for body
size:CI = CO/BSA Normal Cardiac Index is approx.
2.5-3.6 L/min/m2
Mean Arterial Pressure (MAP, mmHg)
Mean Arterial Pressure (MAP, mmHg) = (SBP-DBP)/
3 + DBP
Normal Mean Arterial Pressure is 70-100 mm Hg
Pulse Pressure (PP, mmHg)
Pulse pressure (mmhg) = systolic blood pressure (SBP)
- diastolic blood pressure (DBP)
Left Ventricular End-Systolic Pressure (LVESP,
mmHg)
LVESP = 0.9 * Systolic Blood Pressure (mmHg)
Figure 7 The mechanical events in the cardiac cycle, assembled by Lewis in 1920 but first conceived by Wiggers in 1915. Cycle length
of 800 milliseconds for 75 beats/min. Cardiological systole is demarcated by the interval between the first and the second heart sounds, lasting
from the first heart sound to the closure of the aortic valve. The remainder of the cardiac cycle automatically becomes cardiological diastole. Left
ventricular contraction: isovolumic contraction (b); maximal ejection (c). Let ventricular relaxation: start of relaxation and reduced ejection (d);
isovolumic relaxation (e); LV filling rapid phase (f); slow LV filling (diastasis) (g); atrial systole or booster (a). Mitral valve closure occurs after the
crossover point of atrial and ventricular pressures at the start of systole. A2 = aortic valve closure, aortic component of second sound; AO =
aortic valve opening, normally inaudible; ECG = electrocardiogram; JVP = jugular venous pressure; M1 = mitral component of first sound at time
of mitral valve closure; MO = mitral valve opening, may be audible in mitral stenosis as the opening snap; P2 = pulmonary component of
second sound, pulmonary valve closure; S3 = third heart sound; S4 = fourth heart sound; T1 = tricuspid valve closure, second component of first
heart sound. Modified from Opie LH. Mechanisms of cardiac contraction and relaxation. In: Braunwald E, Zipes DP, Libby P, Bonow RO, eds. Heart
Disease. 7th ed. WB Saunders Company 2005, Chap.19:457-489, page 475.
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The most accurate estimate of LV End-Systolic Pres-
sure is 0.9 * Systolic Blood Pressure [34]. Several aortic
pressures have been proposed as surrogates for LV End-
Systolic Pressure in an attempt to simplify the clinical
assessment of arterial elastance (Ea) and ventricular ela-
stance (Ees). Mean pressure, [35-37] mean ejection pres-
sure, and the (2Systolic Blood Pressure + Diastolic
Blood Pressure)/3 formula [38] significantly underesti-
mated LV End-Systolic Pressure, the bias being higher
in hypertensive patients than in normotensive subjects
in all cases. Conversely, 0.9 * Systolic Blood Pressure
gave a reliable estimate of LV End-Systolic Pressure
whatever the prevailing aortic pressure. Previous results
showed that 1) peak LV pressure is usually achieved
close to the volume point of minimal LV volume [39]2)
peak LV pressure and LV End-Systolic Pressure are
close in magnitude, although they occur at different
points in time [40] and 3) LV peak systolic pressure can
be used instead of LV End-Systolic Pressure to calculate
LV elastance with reasonably good accuracy [41]. The
main clinical implication is that 0.9Systolic Blood Pres-
sure may provide the most accurate estimate of LV
End-Systolic Pressure, and this may improve the nonin-
vasive calculation of ventricular elastance and arterial
elastance (Ees and Ea). Other empirical LV End-Systolic
Pressure estimates must not be used, especially in
hypertensive patients. Importantly, the 0.9Systolic Blood
Pressure approximation applies strictly to central pres-
sure recordings and not to brachial artery pressure,
given the physiological increases in systolic pressure
observed from the aorta to periphery (pulse wave ampli-
fication phenomenon) [42].
End-Systolic Pressure-Volume determination (LVESP/ESV,
mmHg/mL) or Left Ventricular Systolic Elastance, (Ees,
mmHg/mL)
The LVESP/ESV (or end-systolic elastance, Ees) is deter-
mined as the ratio of the end systolic pressure/end-
systolic volume. Because end-systolic volume varies
directly with body size, end-systolic elastance can be
indexed for body surface area (EesI = Ees/BSA, mmHg/mL/
m2) to better reflect differences with age and between the
genders adjusted for differences in body size [43-45].
Arterial Elastance (Ea, LVESP/SV, mmHg/mL)
Arterial elastance is essential to characterize the distal
impedance of the arterial system downstream of the aor-
tic valve. Arterial elastance is calculated as the ratio of
end-systolic pressure (0.9SBP) by stroke volume, and
expressed in the same units as Systolic Pressure/End
Systolic Volume = mmHg/mL. Because stroke volume
(and input impedance) varies directly with body size,
arterial elastance can be adjusted for body surface area
(EaI) to better reflect differences in arterial properties
with age and between the genders adjusted for differ-
ences in body size [46]. This index models the arterial
system as if it were an elastance receiving ejected
volume from the heart and is affected principally by
systemic vascular resistance, heart rate, and arterial
compliance. Arterial elastance is elevated in heart fail-
ure, mainly because of tachycardia, increased systemic
vascular resistance, and a reduction in systemic arterial
compliance, compromising optimal coupling between
the left ventricle and the arterial system.
Ventricular-Arterial Coupling (VAC, ratio)
Ventricular arterial coupling is indexed by the ratio of
left ventricular systolic elastance index (Ees, systolic
pressure/end-systolic volume) to arterial elastance (Ea,
ratio of end-systolic pressure by stroke volume). Of
note, ventricular-arterial coupling is ventricular ela-
stance/arterial elastance, which can further be described
as: end-systolic pressure/end-systolic LV volume divided
by end-systolic pressure/stroke volume: the pressure
terms in the numerator and the denominator cancel
out, and ventricular-arterial coupling equals stroke
volume/end-systolic volume. The noninvasive values of
ventricular-arterial coupling are not dependent on blood
pressure measurements and can be regarded as relatively
accurate [47].
At rest, in healthy individuals, ventricular arterial cou-
pling is maintained within a narrow range, which allows
the cardiovascular system to optimize energetic effi-
ciency at the expense of mechanical efficacy. During
exercise, an acute mismatch between the arterial and
ventricular systems occurs, due to a disproportionate
Table 2 Physiological vs cardiological systole and
diastole
Physiological systole Cardiological systole
Isovolumic contraction From M1 to A2, including:
Maximal ejection
Major part of isovolumic contraction*
Maximal ejection
Reduced ejection
Physiological diastole Cardiological diastole
Reduced ejection A2 - M1 interval (filling phases included)
Isovolumic relaxation
Filling phases
In Greek, systole means contraction and diastole means “to send apart”.
Physiological systole lasts from the start of isovolumic contraction to the peak
of the ejection phase, so that physiological diastole commences as the LV
pressure starts to fall. This concept fits well with the standard pressure-
volume curve. Physiological diastole commences as calcium ions are taken up
into the SR, so that the myocyte relaxation dominates over contraction and
the LV pressure starts to fall as shown on the pressure-volume curve. In
contrast, cardiological systole is demarcated by the interval between the first
and the second heart sounds, lasting from the first heart sound to the closure
of the aortic valve. The remainder of the cardiac cycle automatically becomes
cardiological diastole.
* Note that M1 occurs with a definite albeit short delay after the start of the
LV contraction. Modified from Opie LH. Mechanisms of cardiac contraction
and relaxation. In: Braunwald E, Zipes DP, Libby P, Bonow RO, eds. Heart
Disease. 7th ed. WB Saunders Company 2005, Chap.19:457-489, page 474.
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increase in ventricular systolic elastance index EesI (from
an average of 4.5 to 14.5 mmHg/mL/m2) vs arterial ela-
stance EaI (from an average of 2.3 to 3.2 mmHg/mL/
m2), to ensure that sufficient cardiac performance is
achieved to meet the increased energetic requirements
of the body. As a result ventricular arterial coupling
(EesI/EaI) increases from an average of 1.9 to 4.5 in
normals [48].
Changes in left ventricular-arterial coupling in DCM
patients can be accounted for by both the absence of
increase in the inotropic state of the left ventricle and
by an increase in arterial elastance index. In DCM
patients, ventricular systolic elastance index is almost
equal to half of the arterial elastance index. Tachycardia
exacerbates a baseline suboptimal ventricular-arterial
coupling. As a result, blunted rest ventricular arterial
Figure 8 Operator-independent cardiologic systole and diastole quantification. The transcutaneous force sensor is based on a linear
accelerometer. We housed the device in a small case which is positioned in the mid-sternal precordial region and is fastened by a solid gel ECG
electrode. The acceleration signal is converted to digital and recorded by a laptop PC, together with an ECG signal. An analog peak-to-peak
detector synchronized with the standard ECG scans the first 150 ms following the R wave to record first heart sound force vibrations and the
100 ms following the T wave to record second heart sound force vibrations. A stable, reproducible, and consistent first heart sound and second
heart sound signal is obtained and utilized as time markers to continuously assess cardiologic systole and diastole during exercise, or
pharmacological stress echo. Modified from Bombardini et al. Cardiovascular Ultrasound 2008 6:15 [24].
Table 3 Heart rate and total cardiac cycle duration
HR b.p.m 50 60 70 80 90 100 110 120 130 140 150 160 170 180
Cardiac cycle length (msec) 1200 1000 857 750 666 600 545 500 463 429 400 375 353 333
The total cardiac cycle duration is algebraically dependent on the heart rate [= 60,000 msec/heart rate] with fixed values totally independent from the increasing
heart rate stress type. However, at each heart rate the fixed total cardiac cycle time can be differently divided between systole and diastole. At fixed heart rates
the diastolic time fraction is determined by factors that modulate systolic duration through modulation of myocyte contraction.
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coupling (EesI/EaI) does not significantly increase from
an average of 0.4 to 0.5 in DCM patients [48].
Systemic Vascular Resistance (SVR, dyne*sec*cm-5)
SVR is calculated according to the traditional formula:
SVR 8 MAP 5 CO= −( )0* /
where 5 is an approximation of the right atrial pres-
sure and MAP is mean arterial pressure.
Vascular resistance is a term used to define the resistance
to flow that must be overcome to push blood through the
circulatory system. The resistance offered by the peripheral
circulation is known as the systemic vascular resistance.
The systemic vascular resistance may also be referred to as
the total peripheral resistance. Vasoconstriction (i.e.,
decrease in blood vessel diameter) increases systemic vas-
cular resistance, whereas vasodilatation (increase in dia-
meter) decreases systemic vascular resistance [49]. Units
for measuring vascular resistance are dyne*s*cm-5 or Pascal
seconds per cubic meter (MPa·s/m³) [50]. Pediatric cardiol-
ogists use hybrid reference units (HRU), also known as
Wood units, as they were introduced by Dr. Paul Wood.
To convert from dyne*s*cm-5 to Pascal seconds per
cubic meter (MPa·s/m3), divide by 8.
To convert from dyne*s*cm-5 to Wood units, divide by 80.
Normal systemic vascular resistance is 900-1300
dyne*sec*cm-5 (or 90-130 MPa·s/m3) (or 11-16 Wood
units)
Systemic Arterial Compliance (C, mL/mmHg) Sys-
temic arterial compliance = Stroke Volume/systemic
arterial Pulse Pressure;
where pulse pressure = systolic blood pressure - dia-
stolic blood pressure. Compliance is related to distensi-
bility and arterial diameter [51-53].
Mitral E/e’ (ratio) Using the septal E/è’ ratio, a ratio <
8 is usually associated with normal LV filling pressures,
whereas a ratio > 15 is associated with increased filling
pressures. The E/e’ ratio is among the most reproducible
echocardiographic parameters to estimate the pulmon-
ary capillary wedge pressure and is the preferred
Table 4 Estimation of RA pressure based on Inferior Vena
Cava diameter and collapse
Inferior vena cava diameter
(cm)
Respiratory collapse
(%)
RAP
(mmHg)
<2.1 ≥50% 3 (0-5)
>2.1 <50% 15
>2.1 ≥50% 8 (5-10)
<2.1 <50% 8 (5-10)
RAP = Right atrium pressure
Figure 9 Implementation of the computational training software. Opening a new example by the web linking to http://cctrainer.ifc.cnr.it.
and clicking on “insert case” button a electronic sheet appears. Rest and peak data sets should be filled by the trainer in the fourth and fifth
columns. After inserting the data, the operator clicks the “rest and stress data calculator” button to open the electronic calculation sheet. Each
definition/abbreviation can be expanded to a full description simply pointing the mouse cursor.
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prognostic parameter in many cardiac conditions. Ele-
vated filling pressures are the main physiologic conse-
quence of diastolic dysfunction. Filling pressures are
considered elevated when the mean pulmonary capillary
wedge pressure is > 12 mmHg or when the LV end-dia-
stolic pressure is > 16 mmHg. Using the septal E/e’
ratio, a ratio < 8 is usually associated with normal LV
filling pressures, whereas a ratio > 15 is associated with
increased filling pressures [54,55].
Diastolic filling rate (mean, mL/m2 *sec-1) Diastolic
mean filling rate [24] is calculated at rest and at peak
stress as mitral filling volume (considered equivalent to
the Stroke Volume index) divided by cardiological dia-
stolic time (automatically sensor estimated) × 1,000
Diastolic Mean Filling Rate Stroke Volume index
Cardiolog
= ( /
ical DiastolicTime 1 mL m sec2 1) , / *× ( )−000
The mean filling rate increases threefold in normals
and far less in patients from rest to peak exercise,
suggesting a larger filling capacity in normals. The diag-
nosis of heart failure with normal ejection fraction
requires evidence of diastolic left ventricular dysfunc-
tion, obtained non-invasively by tissue Doppler (E/e’ >
15). However, interpretable E/e’ are not always obtained,
since the most common source of uninterpretable tra-
cings is fusion of E and A velocities due to tachycardia.
The combination of a cutaneous operator-independent
force sensor and 3 D stress echo allows a highly feasible,
rapid and informative assessment of mitral inflow rate,
which could be impaired in presence of diastolic dys-
function and provide insight into a novel form - feasible
at last! - of diastolic stress echocardiography.
Right Ventricular Systolic Pressure (RVSP, mmHg)
and Systolic Pulmonary Artery Pressure (SPAP,
mmHg) Right ventricular systolic pressure can be reli-
ably determined from peak tricuspid regurgitation jet
velocity, using the simplified Bernoulli equation and
combining this value with an estimate of the right
atrium pressure:
Table 5 Rest and stress algorithm set
Calculated values Method Measure unit
Body Surface Area (BSA, at rest) Sq.Root {(Kg.)*(Cm.)/(3600)} M2
(rest, and peak stress)
Stroke Volume (SV) EDV - ESV mL
Cardiac Output (CO) stroke volume * heart rate L/min
Mean Arterial Pressure (MAP) (SBP-DBP)/3 + DBP mmHg
Pulse Pressure (PP) SBP-DBP mmHg
End Systolic Pressure (ESP) SBP * 0.9 mmHg
LV Elastance (Ees) index ESP/ESV * BSA
-1 mmHg/mL/m2
Effective arterial elastance index (Eai) ESP/SV * BSA -1 mmHg/mL/m2
Ventricular-Arterial Coupling (VAC) Ees/Ea = (ESP/ESV)/(ESP/SV) = SV/ESV ratio
Systemic Vascular Resistance (SVR) 80 * (MAP- 5) ⁄ Cardiac output (dyne*sec)/cm5
systemic arterial Compliance (C) Stroke Volume/Pulse Pressure mL/mmHg
Mitral E/e’ ratio
Diastolic Mean Filling Rate (SVi/Cardiological Diastolic Time) × 1,000 mL/m2 × sec-1
Diastolic time/systolic time ratio M-Mode or Sensor ratio
And, for right heart function:
Pulmonary Artery Systolic Pressure (PASP) 4×(Tricuspid regurgitant velocity)2 + Right Atrium Pressure mmHg
Pulmonary Artery Diastolic Pressure
(PADP)
4×(Pulmonary artery end-diastolic velocity)2 + Right Atrium Pressure mmHg
Mean PA Pressure(MPAP) 1/3(SPAP) + 2/3(PADP). mmHg
Mean PA Pressure (MPAP) 4×Peak pulmonary regurgitant velocity2 mmHg
Pulmonary Artery Pulse Pressure (PAPP) 4×(Tricuspid regurgitant velocity)2 - 4×(Pulmonary artery end-diastolic
velocity)2
mmHg
Pulmonary Vascular Resistance (PVR) PVR = 80 × (MPAP - PCWP)/CO (dyne*sec)/cm5
Pulmonary Vascular Resistance (PVR) 10 × Tricuspid regurgitant velocity/PTVI Woods units
X 80 = (dyne*sec)/
cm5
Pulmonary Vascular Capacitance (PVC) Stroke Volume/Pulmonary Artery Pulse Pressure mL/mmHg
SBP = Systolic blood pressure; DBP = Diastolic blood pressure; TR = Tricuspid regurgitation; EDV = End-diastolic volume; ESV = End-systolic volume; RV = Right
ventricular; PCWP = Pulmonary capillary wedge pressure; PTVI = Pulmonary time velocity integral; MPAP = Mean pulmonary artery pressure; SPAP = Systolic
pulmonary artery pressure; PADP = Pulmonary artery diastolic pressure; MAP = Mean arterial pressure; SV = Stroke volume
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Right ventricular systolic pressure  4 tricuspid regurgita= × nt velocity
right atrium pressure mmHg
2( )
+ ( )
or
RVSP 4 V RA pressure
2
= ( ) + ,
where V is the peak velocity (in meters per second)
of the tricuspid valve regurgitant jet, and RA pressure
is estimated from inferior vena cava diameter and
respiratory changes. In the absence of a gradient across
the pulmonary valve or right ventricular outflow tract,
systolic pulmonary artery pressure is equal to right
ventricular systolic pressure. In cases in which right
ventricular systolic pressure is elevated, obstruction at
the level of the right ventricular outflow tract or pul-
monary valve should be excluded, especially in patients
with congenital heart disease or post-pulmonary valve
surgery. Tricuspid regurgitation velocity is usually
obtained with continuous wave Doppler from the RV
Figure 10 Implementation of the computational training software. Once linked to http://cctrainer.ifc.cnr.it., after filling the “insert case sheet”
and clicking on the “rest and stress data calculator” button, the calculation results sheet opens. Calculation algorithms are shown in column 2
and software calculated results appear in the third “rest” and in the fourth “peak “column”. In the sixth column the trainer will find % rest-peak
change values. Each definition/abbreviation can be expanded to a full description simply pointing the mouse cursor.
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inflow or the apical four-chamber view position. Tri-
cuspid regurgitation velocity reflects the pressure dif-
ference during systole between the RV and the right
atrium. Normal resting values are usually defined as a
peak tricuspid regurgitation velocity of < 2.8 to 2.9 m/s
or a peak systolic pressure of 35 or 36 mm Hg, assuming
an right atrium pressure of 3 to 5 mm Hg [56]. This
value may increase with age and increasing body surface
area. Further evaluation of patients with dyspnea
with estimated right ventricular systolic pressure
> 40 mm Hg.
Pulmonary Artery Diastolic Pressure (PADP, mmHg)
Pulmonary artery diastolic pressure can be estimated
from the velocity of the end-diastolic pulmonary regur-
gitant jet using the modified Bernoulli equation:
[Pulmonary Artery Diastolic Pressure
4 end diastolic pulmo= × − nary regurgitant velocity
Right Atrium pressure mmHg
2( )
+ ( )]
The end-diastolic velocity of pulmonary regurgitation
reflects the end-diastolic pressure gradient between the
pulmonary artery and the RV. Normally, the pulmonary
regurgitation end-diastolic pressure gradient is less than
5 mmHg. An increase in this pressure gradient (> 5
mmHg) has been found to correlate with systolic dys-
function, diastolic dysfunction, increased brain natriure-
tic peptide, and decreased functional status [57].
Mean Pulmonary Artery Pressure (Standard formula,
mmHg) Once systolic and diastolic pressures are
known, mean pressure may be estimated by the stan-
dard formula [58]:
Mean Pulmonary Artery Pressure
1/3 Systolic Pulmonary Arter= y Pressure
2/3 Pulmonary Artery Diastolic Pressure
( )
+ ( ) .
Mean Pulmonary Artery Pressure ("Doppler” metho-
dology, mmHg) The Mean Pulmonary Artery Pressure
can also be estimated as:
4 early Pulmonary Regurgitant velocity
estimated Right 
2
× ( )
+ Atrium pressure mmHg( )
Whenever possible, it is helpful to use several methods
to calculate mean pressure so that the internal consis-
tency of the data can be challenged and confirmed.
Pulmonary Artery Pulse Pressure (PAPP, mmHg)
Pulmonary Artery Pulse Pressure
4 Tricuspid Regurgitant ve
=
× locity
4 Pulmonary Artery end diastolic velocity mmH
2
2
( ) −
× −( ) g( )
Pulmonary Vascular Resistance (PVR, measurement
via invasive monitoring, dyne*sec*cm-5) Traditionally,
Pulmonary Vascular Resistance is obtained by cardiac
catheterization, using the following formula:
Pulmonary Vascular Resistance
8 mean PA pressure PCWP C
=
× −( )0 / O dyne sec cm 5( * * )−
where mean PA pressure = Mean Pulmonary Arterial
Pressure and PCWP = Pulmonary CapillaryWedge
Pressure
Normal Pulmonary Vascular Resistance is 100-200
dyn·s*cm-5 (or 10-20 MPa·s/m3) (or 1.25-2.5 Wood units)
Units for measuring vascular resistance are
dyne*·s·*cm-5 or pascal seconds per cubic meter (Pa·s/
m³). Pediatric cardiologists use hybrid reference units
(HRU), also known as Wood units, as they were intro-
duced by Dr. Paul Wood. To convert from Wood units
to MPa·s/m3, multiply by 8; or to dyne*s*cm-5, multiply
by 80 [59]. The pressures are measured in units of milli-
meters of mercury (mmHg) and the cardiac output is
measured in units of liters per minute (L/min).
Pulmonary Vascular Resistance (PVR, measurement
via noninvasive Doppler echocardiography, Wood
units) Doppler echocardiography may provide a reliable,
noninvasive method for determining Pulmonary Vascu-
lar Resistance:
Pulmonary Vascular Resistance Wood units
TRV/TVI 1RVOT
( )
= * 0
Were TRV = peak tricuspid regurgitant velocity (m/s)
And TVI RVOT = right ventricular outflow tract time-
velocity integral (cm)
To convert from Wood units to MPa·s/m3, multiply by
8; to dyne*·s*cm-5, multiply by 80. This relationship is
not reliable in patients with very high Pulmonary Vascu-
lar Resistance, with measured Pulmonary Vascular Resis-
tance > 8 Wood units. An elevation in systolic
pulmonary artery pressure does not always imply an
increased Pulmonary Vascular Resistance, as can be seen
from the relationship whereby Δpressure = flow × resis-
tance. A normal invasively measured Pulmonary Vascular
Resistance is < 1.5 Wood units (< 120 dyne*·s*cm-5), and
for the purpose of clinical studies in pulmonary hyper-
tension, significant pulmonary hypertension is defined as
a Pulmonary Vascular Resistance > 3 Wood units (> 240
dyne*·s*cm-5). Pulmonary Vascular Resistance distin-
guishes elevated pulmonary pressure due to high flow
from that due to pulmonary vascular disease. The estima-
tion of Pulmonary Vascular Resistance may be consid-
ered in subjects in whom pulmonary systolic pressure
may be exaggerated by high stroke volume or mislead-
ingly low (despite increased Pulmonary Vascular
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Resistance) by reduced stroke volume. The noninvasive
estimation of Pulmonary Vascular Resistance should not
be used as a substitute for the invasive evaluation of Pul-
monary Vascular Resistance when this value is important
in order to guide therapy [60-62].
Pulmonary Vascular Capacitance (PVC, mL/mmHg)
Pulmonary Vascular Capacitance Stroke Volume
Pulmonary Art
= /
ery Pulse Pressure mL mmHg/( )
Pulmonary vascular capacitance is a measure of the
workload on the right ventricle, and pulmonary vascular
capacitance determined by cardiac catheterization is a
strong predictor of survival in patients with pulmonary
hypertension. Pulmonary Vascular Capacitance can be
derived noninvasively from a comprehensive 3 D and
Doppler echocardiogram. Using the peak systolic tricus-
pid regurgitation velocity and the end-diastolic pulmon-
ary regurgitation velocity, the modified Bernoulli
equation is used to calculate the Pulmonary Artery sys-
tolic and diastolic pressures, and the Pulmonary Artery
pulse pressure (Pulmonary Artery Pulse Pressure = Pul-
monary Artery Systolic Pressure - Diastolic Pulmonary
Artery Pressure, mmHg). Stroke volume is obtained
using the volumetric flow through the left ventricular
outflow tract, or by end-diastolic volume minus end-sys-
tolic volume. The novel measure of Pulmonary Vascular
Capacitance, as determined by Doppler echocardiogra-
phy, is a strong noninvasive predictor of mortality in
patients with Pulmonary Hypertension and adds prog-
nostic value to conventional risk markers. Mahapatra
studied the prognostic value of pulmonary vascular
capacitance determined by Doppler echocardiography in
patients with pulmonary arterial hypertension and
showed that in quartile analysis the lowest Pulmonary
Vascular Capacitance quartile had a 4-year mortality of
39% whereas the highest Pulmonary Vascular Capaci-
tance quartile had a mortality of 7% [63-65].
Measurement of Systolic Pulmonary Artery Pressure
during exercise (SPAP, mmHg) In normal subjects,
exercise increases the stroke volume while the pulmon-
ary vascular resistance decreases. Normal values are
defined by Systolic Pulmonary Artery Pressure < 43
mmHg during exercise [27,66]. In well-trained athletes
or those aged > 55 years, systolic Pulmonary Artery
pressure as high as 55 to 60 mmHg at peak exercise is
encountered. A pulmonary hypertensive response dur-
ing exercise can be clinically important in several con-
ditions, including valvular heart disease, heart failure,
and Pulmonary Hypertension. From the pathophysiolo-
gic viewpoint, on the basis of the fundamental equa-
tion of flow (Flow = ΔPressure/Resistance), the
abnormal exercise-induced increase in pressure can be
ascribed to supranormal cardiac output (eg, in athletes)
or to a normal increase in flow but a rise in resistance
due to limited capability of the pulmonary vascular
bed (eg, in chronic obstructive pulmonary disease or
congenital heart disease) [27,67]. In this setting, the
ratio of Δpressure (estimated by Tricuspid Regurgita-
tion velocity) to flow (estimated by the RVOT time-
velocity integral, or by the formula heart rate * stroke
volume) may be helpful in distinguishing whether
the increased pressure is related to an increase in flow
or in resistance [27]. In patients with dyspnea of
unknown etiology, with normal resting echocardio-
graphic results and no evidence of coronary artery
disease, it is reasonable to perform stress echocardio-
graphy to assess stress-induced Pulmonary Hyperten-
sion [27]. This technique should be considered as well
in subjects with conditions associated with Pulmonary
Hypertension. Supine bicycle exercise is the preferred
method for Systolic Pulmonary Artery Pressure mea-
surement. An upper limit of 43 mm Hg should be
used in patients at non-extreme workloads. In subjects
with valvular heart disease, the American College of
Cardiology and American Heart Association cutoffs
should be used to help guide management [27].
Pulmonary Capillary Wedge Pressure (PCWP, mmHg)
Pulmonary artery wedged pressure (also called pulmon-
ary artery occlusion pressure or PAOP) is a measurement
in which one of the pulmonary arteries is occluded, and
the pressure downstream from the occlusion is measured
in order to approximately sample the left atrial pressure.
The catheter is threaded from peripheral vein into vena
cava right atrium, right ventricle, pulmonary artery, and
finally “wedged” with a balloon in a branch of the pul-
monary artery. Because the catheter blocks flow, the
pressure looks at the venous end of pulmonary circula-
tion. Pulmonary Capillary Wedge Pressure estimates left
atrial pressure.
Normal values:
Right atrial pressure. Mean value near 0 mmHg.
Right ventricle. Systolic = 25 mmHg. Diastolic = 0
mmHg.
Pulmonary artery. Mean value about 15 mmHg. Systo-
lic about 25 mmHg. Diastolic about 8 mmHg.
Left atrial pressure. Mean about 5 mmHg.
An estimation of pulmonary capillary wedge pressure
can be noninvasively assessed using the ratio of transmi-
tral E velocity to the early diastolic mitral annulus velo-
city (e’), with the formula: Pulmonary Capillary Wedge
Pressure (PCWP) = (1.24 × [E/e’]) + 1.9 (mmHg)
Elevated filling pressures are the main physiologic
consequence of diastolic dysfunction. Filling pressures
are considered elevated when the mean pulmonary
capillary wedge pressure is >12 mmHg or when the LV
End-Diastolic Pressure is >16 mmHg. Using the septal
E/e´ ratio, a ratio < 8 is usually associated with normal
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LV filling pressures, whereas a ratio >15 is associated
with increased filling pressures [54,55].
Right Ventricular Diastolic Dysfunction
A growing number of acute and chronic conditions have
been associated with RV diastolic dysfunction, including
both pressure and volume overload pathologies, primary
lung disease, ischemic heart disease, congenital heart
disease, cardiomyopathies, LV dysfunction (via ventricu-
lar interdependence), systemic diseases, and the physio-
logic aging process [27]. The parameters used to assess
RV diastolic function are essentially the same as those
used to assess the left side. The ones that have been
most validated are Doppler velocities of the transtricus-
pid flow (E, A, and E/A), tissue Doppler velocities of the
tricuspid annulus (E’, A’, E’/A’), deceleration time, and
isovolumic relaxation time (IVRT, msec). The tricuspid
E/E’ ratio, Right Atrium area or volume, and diastolic
strain rate appear promising and have attracted interest
in recent studies. Because of its thin wall, the right ven-
tricle is very sensitive to afterload (wall stress), and it is
also sensitive to changes in preload. The tricuspid E/E’
ratio and Right Atrium volume have been shown to cor-
relate well with hemodynamic parameters. Measurement
of RV diastolic function should be considered in
patients with suspected RV impairment as a marker of
early or subtle RV dysfunction, or in patients with
known RV impairment as a marker of poor prognosis.
Grading of RV diastolic dysfunction should be done as
follows: tricuspid E/A ratio < 0.8 suggests impaired
relaxation, a tricuspid E/A ratio of 0.8 to 2.1 with an E/
E’ ratio > 6 or diastolic flow predominance in the hepa-
tic veins suggests pseudonormal filling, and a tricuspid
E/A ratio > 2.1 with a deceleration time < 120 ms sug-
gests restrictive filling (as does late diastolic antegrade
flow in the pulmonary artery). Further studies are war-
ranted to validate the sensitivity and specificity and the
prognostic implications of this classification.
Testing
To test the WEB downloadable software for training in
noninvasive cardiovascular hemodynamics, anonymous
standard stress echo reports with baseline and stress
measurements were submitted to 10 skilled echocardio-
graphers (American Society of Echocardiography class III).
Each echocardiographer was asked to calculate hemody-
namic parameters starting from the sets of rest and stress
measurements with two modalities (Table 6). A first set of
calculations (Mode 1) was made by simply using personal
knowledge of hemodynamic formulas and/or helping
themselves with standard text books of cardiology. A sec-
ond set of calculations (Mode 2) was made by using the
web downloadable software. In both modalities (Mode 1
and Mode 2) the times needed for calculation and exact-
ness of calculations were computed and compared. The
time of calculation was 55 ± 63 min in mode 1 and 2 ± 0.5
min in mode 2 (p < 0.05 vs Mode 1). The exactness of cal-
culations was 75 ± 20% in mode 1 and 100 ± 0% in mode
2 (p < 0.01 vs Mode 1).
Implementation
The informatics infrastructure is available on the web,
linking to http://cctrainer.ifc.cnr.it. Algorithms and data
sheets can be freely downloaded by the WEB. Measures
and indexes are obtained automatically by software pro-
cessing. The exporting data in excel or SPSS format is pos-
sible for shorten calculations and to store data. Examples
of the web downloadable “rest and stress parameters” elec-
tronic sheet is shown in Figure 9 and an example of the
“calculated results” electronic sheet is shown in Figure 10.
Images of graphically displayed results in a normal and
DCM subject are shown in Figure 11 and Figure 12.
Discussion
Clinical use of modern 3 D echocardiography is boosted
by the marked reduction in acquisition time and the
unique possibility of online rendering on the ultrasound
system. The ability to visualize a virtual 3 D surface in real
time - although limited to a sector size of about 30 degrees
- offers new insights into cardiac pathomorphology even
in patients with arrhythmias. Analysis of wide-angle 3 D
datasets (90 by 90 degree pyramidal shape) is possible by
combining the 3 D information of several [2-6] consecu-
tive heart cycles. Three-dimensional (3D) volumetric ima-
ging has potential advantages in stress echocardiography,
Table 6 Testing the web downloadable software
Cardiologist # 1 2 3 4 5 6 7 8 9 10
Mode 1 (subjective knowledge)
Time for calculation (min) 20 21 9 15 9 120 115 190 22 29
Exactness of calculations (exact/wrong, % of exactness) 34/6 32/8 16/24 24/16 28/12 38/2 40/0 40/0 22/18 26/14
85% 80% 40% 60% 70% 95% 100% 100% 55% 65%
Mode 2 (WEB software)
Time for calculation (min) 2 1,5 1,6 2 3 2 2 2,5 1,3 1,7
Exactness of calculations (exact/wrong, % of exactness) 40/0 40/0 40/0 40/0 40/0 40/0 40/0 40/0 40/0 40/0
100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
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including the ability to provide an unlimited number of
planes for analysis.
Combination with 3 D color Doppler data allows addi-
tional assessment of valvular function as well as determi-
nation of flow in the left ventricular outflow tract and
across septal defects. Dedicated software systems and tech-
nologies have been developed based on high-performance
computers designed for graphic handling of three-
dimensional images by providing possibilities beyond
those obtainable with 2 D echocardiography. Beyond this,
echocardiography enables the cardiologist to measure and
calculate over 30 different noninvasive parameters
including cardiac chamber size, indices of left ventricular
performance, and estimates of mean left atrial pressure.
However, the entire procedure requires meticulous mea-
surements and time-consuming calculations, particularly
when some of the data must be corrected for heart rate or
body size. Because of this, many busy noninvasive cardiac
laboratories routinely calculate only a few selected para-
meters in most patients. This problem of calculation is
strongly amplified in the stress echo lab, since the 30 dif-
ferent noninvasive parameters become 60 if we also have
to calculate peak stress data, 90 if we want to calculate
rest-peak stress changes, and even more if we want to
Figure 11 Training example with a “normal subject” data set. Clicking on the “view graphics” button opens the graph results sheet. For
each calculated variable rest-peak changes are graphically displayed with heart rate values on the x-axis and variable value on the y-axis. LV
elastance index at peak stress is nearly twice as large as arterial elastance index, with ventricular-arterial coupling normally set toward higher left
ventricular work efficiency. Stroke volume increases through the use of the Frank-Starling mechanism and heart rate. Systemic vascular
resistances drop markedly at peak exercise.
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graphically display results. Quantitative and accurate cal-
culation of a set of parameters allowing a complete charac-
terization of cardiovascular hemodynamic needs data to be
implemented in formulas - and until now, little or nothing
has been done to help cardiologists utilize these data prac-
tically in the everyday busy echocardiography lab. In this
paper we have shown how a simple web downloadable cal-
culation trainer could greatly simplify the use and speed of
calculation of a complete set of cardiologic parameters.
Limitations of the study
3 D stress echocardiography
The success of imaging is high with pharmacologic stress
but the feasibility is not established with exercise stress.
The lower spatial and temporal resolution of 3 D imaging
and artifacts introduced by suboptimal subvolume
integration are limitations of the current 3 D techni-
que. The ability to provide more planes for analysis
has not been clearly shown to improve the accuracy of
stress echocardiography. However, 3 D imaging elimi-
nates apical foreshortening, which is common with 2
D imaging, and may improve detection of apical wall
motion abnormalities. Development of automated
image registration, quantitative analysis techniques,
and single beat acquisition is needed to fully exploit
the potential of 3 D imaging in the stress laboratory
[68,69].
Doppler indexes of diastolic function
A potential limitation of this study is the lack of infor-
mation regarding Doppler indexes of diastolic function
or dysfunction during stress. Doppler echocardiography
Figure 12 Training example with a “DCM subject” data set. Clicking on the “view graphics” button opens the graph results sheet. For each
calculated variable rest-peak changes are graphically displayed with heart rate values on the x-axis and variable value on the y-axis. LV elastance
index is markedly lower at peak exercise. At peak stress ventricular elastance index is less than one-half of the arterial elastance index, which
results in decreased ventricular-arterial coupling and work efficiency. DCM patients display a vasoconstrictive response in peripheral circulation,
with a modest and inconsistent decrease of SVR and a more marked drop of arterial compliance at peak stress.
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is the preferred method for non-invasive diastolic func-
tion assessment. In current practice, most diastolic func-
tion indexes are derived by visual inspection of
transmitral E- and A-waves [70]. However during exer-
cise E- and A-waves become difficult to separate and
discern when the A-wave merges with the E-wave and
covers more than two-thirds of the E-wave deceleration,
which typically occurs at heart rate > 100 beats/min.
Furthermore, details of E and A waves are not reliably
discernable above 120 bpm due to noise and resolution
limitations [71]. Despite diastolic heart failure currently
accounts for more than 50% of all heart failure patients
and stress echocardiography is useful for the evaluation
of patients with dyspnoea of possible cardiac origin, dif-
ficulties exist in assessing variables that influence cardiac
diastolic filling during exercise.
The E/e´ ratio has been applied for that objective. In
subjects with normal myocardial relaxation, E and e´
velocities increase proportionally, and the E/e´ ratio
remains unchanged or is reduced. However, in patients
with impaired myocardial relaxation, the increase in e´
with exercise is much less than that of mitral E velocity,
such that the E/e´ ratio increases. In that regard, E/e´
was shown to relate significantly to LV filling pressures
during exercise, when Doppler echocardiography was
acquired simultaneously with cardiac catheterization
[72,73].
In cardiac patients, mitral E velocity increases with exer-
tion and stays increased for a few minutes after the termi-
nation of exercise, whereas e´ velocity remains reduced at
baseline, exercise, and recovery. Therefore, E and e´ velo-
cities can be recorded after exercise, after 2 D images have
been obtained for wall motion analysis. However, the pau-
city of clinical data and the potential limitations in patients
with regional LV dysfunction, mitral valve disease, and
atrial fibrillation preclude recommendations for its routine
clinical use at this time [54,55].
The combination of a cutaneous operator independent
force sensor and 3 D stress echo allows a highly feasible,
fast and informative assessment of mitral inflow rate,
which could be impaired in presence of diastolic dys-
function and provide insight on a novel form of diastolic
stress echocardiography [24].
Diastolic Mean Filling Rate calculation
For the calculation of the Diastolic Mean Filling Rate we
utilized the automatically sensor estimated cardiological
diastolic time that overestimates the diastolic filling
time. In fact, the cardiological diastolic time comprises
diastolic filling time, the A2 - Mitral Opening interval
(isovolumic relaxation) and the beginning of isovolumic
contraction (mitral valve closure occurs with a definite
albeit short delay after the start of the LV contraction)
(Table 2). This certainly introduces an approximation;
nevertheless, any error is systematically distributed from
rest to peak stress, probably not affecting the slope
values of this novel form of diastolic stress echocardio-
graphy. Filling volume is the numerator and the cardio-
logical diastolic time is the denominator of the equation.
An overestimation of diastolic filling time (in the pre-
sence of increased isovolumic relaxation time or of
increased pre-ejection time) strengthens the clinical
information given to a larger filling capacity at peak
stress.
Conclusions
After training one should be able to 1) list several func-
tional parameters of the heart and vascular system at rest
and during stress; 2) give typical values for systolic, dia-
stolic and mean pressures in the systemic and pulmonary
arterial system; 3) calculate arterial elastance from pres-
sure and volume values, and know the steady (systemic
vascular resistance) and pulsatile (systemic arterial com-
pliance) components of the arterial elastance; 4) calculate
left ventricular systolic elastance and the interaction of
the LV with the arterial system, termed ventricular-
arterial coupling, that is a central determinant of cardio-
vascular performance and cardiac energetics; 5) calculate
pulmonary vascular resistance and pulmonary vascular
capacitance; 6) calculate patterns of diastolic function
and dysfunction at rest and during stress.
Abbreviations
A2: aortic valve closure, aortic component of second sound; ASE: American
Society of Echocardiography; BSA: Body surface area; C: Systemic arterial
compliance; CO: Cardiac output; CI: Cardiac index; DBP: Diastolic blood
pressure; Ea: Effective arterial elastance; Ees: Left ventricular elastance; EF:
Ejection fraction; ESP: End systolic pressure; IVC: Inferior vena cava; IVCT:
Isovolumic contraction time; IVRT: Isovolumic relaxation time; LV: Left
ventricle; M1 : mitral component of first sound at time of mitral valve
closure; MAP: Mean arterial pressure; P2 : pulmonary component of second
sound; PA: Pulmonary artery; PADP: Pulmonary artery diastolic pressure;
PAPP: Pulmonary artery pulse pressure; PCWP: Pulmonary capillary wedge
pressure; PH: Pulmonary hypertension; PP: Pulse pressure; PVR: Pulmonary
vascular resistance; PVC: Pulmonary vascular capacitance; RA: Right atrium;
RV: Right ventricle; RVOT: Right ventricular outflow tract; RVSP: Right
ventricular systolic pressure; SBP: Systolic blood pressure; SPAP: Systolic
pulmonary artery pressure; SV: Stroke volume; SVR: Systemic vascular
resistance; T1 : tricuspid valve closure, second component of first heart
sound; 3 D: Three-dimensional; TR: Tricuspid regurgitation; TVI: Time velocity
integral; 2 D: Two-dimensional; VAC: Ventricular arterial coupling.
Acknowledgements
We are grateful to Alison Frank for copyediting/proofreading the English in
this manuscript.
No relationship with industry exists.
Disclaimer. The Authors makes no express or implied warranties regarding
the completeness or accuracy of the information in this report, including the
warranty of marketability or fitness for a particular purpose. In no event shall
the Authors be liable to you, your patients, or any other third parties for any
decision made or action taken by you or such other parties in reliance on
this information. Nor does your use of this information constitute the
offering of medical advice by the Authors or create any physician-patient
relationship between the Authors and your patients or anyone else. The
noninvasive estimation of hemodynamic parameters should not be used as
Bombardini et al. Cardiovascular Ultrasound 2010, 8:48
http://www.cardiovascularultrasound.com/content/8/1/48
Page 19 of 22
a substitute for invasive evaluation when this value is needed to guide
therapy.
Linking to: http://cctrainer.ifc.cnr.it. This software was designed to be used
only for research purposes. Clinical uses are not recommended, and have
never been evaluated. This software comes with no warranties of any kind.
Use it at your own risk! If these terms are not acceptable, you are not
allowed to use http://cctrainer.ifc.cnr.it.
Author details
1Institute of Clinical Physiology, CNR, Pisa, Italy. 2Department of Surgery and
Transplants, University of Bologna, Italy.
Authors’ contributions
TB conceived this study, developed the SW system, performed the data
analysis, and drafted the manuscript; DC participated in the development of
the web system; GA contributed to data discussion; EPi contributed to the
preparation of study design, data discussion, and critical revision of the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 October 2010 Accepted: 13 November 2010
Published: 13 November 2010
References
1. Picano E: Stress Echocardiography. Springer-Verlag Berlin Heidelberg;, 5
2009.
2. Jacobs LD, Salgo IS, Goonewardena S, Weinert L, Coon P, Bardo D,
Gerard O, Allain P, Zamorano JL, de Isla LP, Mor-Avi V, Lang RM: Rapid
online quantification of left ventricular volume from real-time three-
dimensional echocardiographic data. Eur Heart J 2006, 27:460-468.
3. Mor-Avi V, Sugeng L, Lang MR: Real-Time 3Dimensional
Echocardiography: an integral component of the routine
echocardiographic examination in adult patients? Circulation 2009,
119:314-29.
4. Delgado V, Bax JJ, Van Der Wall EE: Towards assessment of left ventricular
mechanics in true three dimensions. Eur Heart J 2009, 30:554-55.
5. Nesser HJ, Mor-Avi V, Gorissen W, Weinert L, Steringer-Mascherbauer R,
Niel J, Sugeng L, Lang RM: Quantification of left ventricular volumes
using three-dimensional echocardiographic speckle tracking: comparison
with MRI. Eur Heart J 2009, 30:1565-73.
6. Mor-Avi V, Sugeng L, Weinert L, MacEneaney P, Caiani EG, Koch R, Salgo IS,
Lang RM: Fast measurement of left ventricular mass with real-time three
dimensional echocardiography: comparison with magnetic resonance
imaging. Circulation 2004, 110:1814-18.
7. Suga H, Sagawa K, Shoukas AA: Load independence of the instantaneous
pressure-volume ratio of the canine left ventricle and effects of
epinephrine and heart rate on the ratio. Circ Res 1973, 32:314.
8. Chantler PD, Lakatta EG, Najjar SS: Arterial-ventricular coupling:
mechanistic insight into cardiovascular performance at rest and during
exercise. J Appl Physiol 2008, 105:1342-51.
9. Otsuki T, Maeda S, Iemitsu M, Saito Y, Tanimura Y, Ajisaka R, Miyauchi T:
Systemic arterial compliance, systemic vascular resistance, and effective
arterial elastance during exercise in endurance trained men. Am J Physiol
Regul Integr Comp Physiol 2008, 295:R228-R235.
10. Bombardini T, Nevola E, Giorgetti A, Landi P, Picano E, Neglia D: Prognostic
value of left-ventricular and peripheral vascular performance in patients.
J Nucl Cardiol 2008, 15:353-62.
11. Bombardini T: Myocardial contractility in the echo lab: molecular, cellular
and pathophysiological basis. Cardiovascular ultrasound 2005, 3:27.
12. Nutter D: Measuring and recording systemic blood pressure. In The heart..
4 edition. Edited by: Hurst JW, Logue RB, Schlant R, Wenger NK. New York:
McGraw-Hill; 1978:220-2.
13. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H,
Gutgesell H, Reichek N, Sahan D, Schnittger I: Recommendations for
quantitation of the left ventricle by two-dimensional echocardiography.
American Society of Echocardiography Committee on Standards,
Subcommittee on Quantification of Two-Dimensional Echocardiograms.
J Am Soc Echocardiogr 1989, 2:362-67.
14. Corsi C, Lang RM, Veronesi F, Weinert L, Caiani EG, MacEneaney P,
Lamberti C, Mor-Avi V: Volumetric quantification of global and regional
left ventricular function from real-time three-dimensional
echocardiographic images. Circulation 2005, 112:1161-70.
15. Lang RM, Mor-Avi V, Sugeng L, Nieman PS, Sahn DJ: Three-dimensional
echocardiography: the benefits of the additional dimension. J Am Coll
Cardiol 2006, 48:2053-69.
16. Boudoulas H, Rittgers L, Leier CV, Weissler AM: Changes in diastolic time
with various pharmacologic agents: implication for myocardial perfusion.
Circulation 1979, 60:164-69.
17. Merkus D, Kajiya F, Vink H, Vergroesen I, Dankelman J, Goto M, Spaan JA:
Prolonged diastolic time fraction protects myocardial perfusion when
coronary blood flow is reduced. Circulation 1999, 100:75-81.
18. Plehn G, Vormbrock J, Zuhlke C, Christ M, Perings C, Perings S, Trappe HJ,
Meissner A: Disproportionate shortening of left ventricular diastolic
duration in patients with dilated cardiomyopthy. Med Klin 2007,
102(9):707-13.
19. Friedberg MK, Silverman NH: Cardiac ventricular diastolic and systolic
duration in children with heart failure secondary to idiopathic dilated
cardiomyopathy. Am J Cardiol 2006, 97:101-05.
20. Chung S, Karamanoglu M, Kovács SJ: Duration of diastole and its phases
as a function of heart rate during supine bicycle exercise. Am J Physiol
Heart Circ Physiol 2004, 287:H2003-H2008.
21. Friedberg MK, Silverman NH: Cardiac ventricular diastolic and systolic
duration in children with heart failure secondary to idiopathic dilated
cardiomyopathy. Am J Cardiol 2006, 97:101-105.
22. Bombardini T, Gemignani V, Bianchini E, Venneri L, Petersen C, Pasanisi E,
Pratali L, Pianelli M, Faita F, Giannoni M, Picano E: Cardiac reflections and
natural vibrations. Force-frequency relation recording system in the
stress echo lab. Cardiovasc Ultrasound 2007, 5(1):42..
23. Bombardini T: Method and device for the diagnosis and therapy of
chronic heart failure. United States Patent 2005, US 6,859,662 B2.
24. Bombardini T, Gemignani V, Bianchini E, Venneri L, Petersen C, Pasanisi E,
Pratali L, Alonso-Rodriguez D, Pianelli M, Faita F, Giannoni M, Arpesella G,
Picano E: Diastolic Time - Frequency Relation in the Stress Echo Lab.
Filling timing and flow at different heart rates. Cardiovasc Ultrasound
2008, 6:15.
25. Fokkema DS, VanTeeffelen J, Dekker S, Vergroesen I, Reitsma JB, Spaan J:
Diastolic time fraction as a determinant of subendocardial perfusion. Am
J Physiol Heart Circ Physiol 2005, 288:H2450-H2456.
26. Yock PG, Popp RL: Noninvasive estimation of right ventricular systolic
pressure by Doppler ultrasound in patients with tricuspid regurgitation.
Circulation 1984, 70:657-62.
27. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD,
Chandrasekaran K, Solomon SD, Louie EK, Schiller NB: Guidelines for the
echocardiographic assessment of the right heart in adults: a report from
the American Society of Echocardiography endorsed by the European
Association of Echocardiography, a registered branch of the European
Society of Cardiology, and the Canadian Society of Echocardiography. J
Am Soc Echocardiogr 2010, 23(7):685-713.
28. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA:
Recommendations for quantification of Doppler echocardiography: a
report from the Doppler Quantification Task Force of the Nomenclature
and Standards Committee of the American Society of Echocardiography.
J Am Soc Echocardiogr 2002, 15:167-84.
29. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE,
Corretti MC, Hassoun PM: Accuracy of Doppler echocardiography in the
hemodynamic assessment of pulmonary hypertension. Am J Respir Crit
Care Med 2009, 179:615-21.
30. Ristow B, Schiller NB: Stepping away from ritual right heart
catheterization into the era of noninvasively measured pulmonary artery
pressure. J Am Soc Echocardiogr 2009, 22:820-2.
31. Qin JX, Jones M, Shiota T, Greenberg NL, Tsujino H, Firstenberg MS,
Gupta PC, Zetts AD, Xu Y, Ping Sun J, Cardon LA, Odabashian JA,
Flamm SD, White RD, Panza JA, Thomas JD: Validation of real-time three-
dimensional echocardiography for quantifying left ventricular volumes
in the presence of a left ventricular aneurysm: in vitro and in vivo
studies. J Am Coll Cardiol 2000, 36(3):900-7.
32. Pemberton J, Li X, Karamlou T, Sandquist CA, Thiele K, Shen I,
Ungerleider RM, Kenny A, Sahn DJ: The use of live three-dimensional
Bombardini et al. Cardiovascular Ultrasound 2010, 8:48
http://www.cardiovascularultrasound.com/content/8/1/48
Page 20 of 22
Doppler echocardiography in the measurement of cardiac output: an in
vivo animal study. J Am Coll Cardiol 2005, 45(3):433-8.
33. Arai K, Hozumi T, Matsumura Y, Sugioka K, Takemoto Y, Yamagishi H,
Yoshiyama M, Kasanuki H, Yoshikawa J: Accuracy of measurement of left
ventricular volume and ejection fraction by new real-time three-
dimensional echocardiography in patients with wall motion
abnormalities secondary to myocardial infarction. Am J Cardiol 2004,
94:552-58.
34. Chemla D, Antony I, Lecarpentier Y, Nitenberg A: Contribution of systemic
vascular resistance and total arterial compliance to effective arterial
elastance in humans. Am J Physiol Heart Circ Physiol 2003, 285(2):H614-20.
35. Asanoi HS, Sasayama S, Kameyama T: Ventriculoarterial coupling in normal
and failing heart. Circ Res 1989, 65:488-493.
36. Colin P, Slama M, Vahanian A, Lecarpentier Y, Motte´ G, Chemla D:
Hemodynamic correlates of effective arterial elastance before and after
balloon valvotomy. J Appl Physiol 1997, 83:1083-89.
37. Grossman W, Braunwald E, Mann T, McLaurin T, Green LH: Contractile state
of the left ventricle in man as evaluated from end-systolic pressure-
volume relations. Circulation 1977, 56:845-52.
38. Kelly RP, Ting C-T, Yang T-M, Liu C-P, Maughan WL, Chang M-S, Kass DA:
Effective arterial elastance as index of arterial vascular load in humans.
Circulation 1992, 86:513-21.
39. Suga H, Sagawa K: Instantaneous pressure-volume relationships and their
ratio in the excised, supported canine left ventricle. Circ Res 1974,
35:117-26.
40. Horwitz LD, Bishop VS: Left ventricular pressure-dimension relationships
in the conscious dog. Cardiovasc Res 1972, 6:163-71.
41. Kono A, Maughan WL, Sunagawa K, Hamilton K, Sagawa K, Weisfeldt ML:
The use of left ventricular end-ejection pressure and peak pressure in
the estimation of the end-systolic pressure-volume relationship.
Circulation 1984, 70:1057-65.
42. O’Rourke M: Mechanical principles in arterial disease. Hypertension 1995,
26:2-9.
43. Bombardini T, Correia MJ, Cicerone C, Agricola E, Ripoli A, Picano E: Force-
frequency Relationship in the Echocardiography Laboratory: A
Noninvasive Assessment of Bowditch Treppe? J Am Soc Echocardiogr
2003, 16:646-55.
44. Grosu A, Bombardini T, Senni M, Duino V, Gori M, Picano E: Endsystolic
Pressure/Volume relations during dobutamine stress echo: a
prognostically useful noninvasive index of left ventricular contractility.
Eur Heart J 2005, 26:2404-12.
45. Bombardini T, Agrusta M, Natsvlishvili N, Solimene F, Pap R, Coltorti F,
Varga A, Mottola G, Picano E: Noninvasive assessment of left ventricular
contractility by pacemaker stress echocardiography. Eur J Heart Fail 2005,
7:173-81.
46. Kass DA: Effective arterial elastance as index of arterial vascular load in
humans. Circulation 1992, 86:513-21.
47. Bombardini T, Nevola E, Giorgetti A, Landi P, Picano E, Neglia D: Prognostic
value of left-ventricular and peripheral vascular performance in patients
with dilated cardiomyopathy. J Nucl Cardiol 2008, 15:353-62.
48. Little WC, Cheng CP: Effect of exercise on left ventricular-arterial coupling
assessed in the pressure-volume plane. Am J Physiol 1993, 264:H1629-33.
49. Otsuki T, Maeda S, Iemitsu M, Saito Y, Tanimura Y, Ajisaka R, Miyauchi T:
Contribution of systemic arterial compliance and systemic vascular
resistance to effective arterial elastance changes during exercise in
humans. Acta Physiol 2006, 188:15-20.
50. Opie LH: Mechanisms of cardiac contraction and relaxation. In Heart
Disease. Volume 19.. 7 edition. Edited by: Braunwald E, Zipes DP, Libby P,
Bonow RO. WB Saunders Company; 2005:457-489, page 475.
51. Maughan WL, Sunagawa K, Burkhoff D, Sagawa K: Effects of arterial
impedance changes on the end-systolic pressure volume relation. Circ
Res 1984, 54:595-602.
52. De Simome GRM, Daniels SR, Mureddu G, Kimball TR, Greco R, Devereux RB:
Age-related changes in total arterial capacitance from birth to maturity
in a normotensive population. Hypertension 1997, 29:1213-7.
53. Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM,
Flaker GC, Pfeffer MA: Sphygmomanometrically determined pulse
pressure is a powerful independent predictor of recurrent events after
myocardial infarction in patients with impaired left ventricular function:
SAVE investigators, survival and ventricular enlargement. Circulation 1997,
96:4254-60.
54. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA,
Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A:
Recommendations for the evaluation of left ventricular diastolic function
by echocardiography. Eur J Echocardiogr 2009, 10(2):165-93.
55. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: Dopper
tissue imaging: A noninvasive technique for evaluation of left ventricular
relaxation and estimation of filling pressures. J Am Coll Cardiol 1997,
30:1527-33.
56. Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair DD, Reeder GS,
Nishimura RA, Tajik AJ: Continuous wave Doppler determination of right
ventricular pressure: a simultaneous Doppler-catheterization study in
127 patients. J Am Coll Cardiol 1985, 6:750-6.
57. Milan A, Magnino C, Veglio F: Echocardiographic indexes for the
noninvasive evaluation of pulmonary hemodynamics. J Am Soc
Echocardiogr 2010, 23:225-39.
58. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Lindner JR, Mathier MA,
McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J: ACCF/
AHA 2009 expert consensus document on pulmonary hypertension: a
report of the American College of Cardiology Foundation Task Force on
Expert Consensus Documents and the American Heart Association
developed in collaboration with the American College of Chest
Physicians; American Thoracic Society, Inc.; and the Pulmonary
Hypertension Association. J Am Coll Cardiol 2009, 53:1573-619.
59. Grünig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T,
Galié N, Ghofrani A, Harrison RE, Huez S, Humbert M, Janssen B, Kober J,
Koehler R, Machado RD, Mereles D, Naeije R, Olschewski H, Provencher S,
Reichenberger F, Retailleau K, Rocchi G, Simonneau G, Torbicki A,
Trembath R, Seeger W: Stress Doppler echocardiography in relatives of
patients with idiopathic and familial pulmonary arterial hypertension:
results of a multicenter European analysis of pulmonary artery pressure
response to exercise and hypoxia. Circulation 2009, 119:1747-57.
60. Kimberly B, Ulett BS, Marwick HThomas: Incorporation of Pulmonary
Vascular Resistance Measurement into Standard Echocardiography:
Implications for Assessment of Pulmonary Hypertension.
Echocardiography 2007, 24:1022-22.
61. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ: A
simple method for noninvasive estimation of pulmonary vascular
resistance. J Am Coll Cardiol 2003, 41:1021-27.
62. Scapellato F, Temporelli PL, Eleuteri E, Corrà U, Imparato A, Giannuzzi P:
Accurate noninvasive estimation of pulmonary vascular resistance by
Doppler echocardiography in patients with chronic failure heart failure. J
Am Coll Cardiol 2001, 37:1813-19.
63. Friedberg MK, Feinstein JA, Rosenthal DN: Noninvasive assessment of
pulmonary arterial capacitance by echocardiography. J Am Soc
Echocardiogr 2007, 20:186-90.
64. Mahapatra S, Nishimura RA, Oh JK, McGoon MD: The prognostic value of
pulmonary vascular capacitance determined by Doppler
echocardiography in patients with pulmonary arterial hypertension. J
Am Soc Echocardiogr 2006, 19:1045-50.
65. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD: Relationship of
pulmonary arterial capacitance and mortality in idiopathic pulmonary
arterial hypertension. J Am Coll Cardiol 2006, 47(4):799-803.
66. Bossone E, Rubenfire M, Bach DS, Ricciardi M, Armstrong WF: Range of
tricuspid regurgitation velocity at rest and during exercise in normal
adult men: implications for the diagnosis of pulmonary hypertension. J
Am Coll Cardiol 1999, 33:1662-6.
67. Grünig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C,
Olschewski H, Kuecherer HF, Kübler W: Abnormal pulmonary artery
pressure response in asymptomatic carriers of primary pulmonary
hypertension gene. Circulation 2000, 102:1145-50.
68. Ahmad M, Xie T, McCulloch M, Abreo G, Runge M: Real-time three-
dimensional dobutamine stress echocardiography in assessment of
ischemia: comparison with two-dimensional dobutamine stress
echocardiography. J Am Coll Cardiol 2001, 37:1303-09.
69. Matsumura Y, Hozumi T, Arai K, Sugioka K, Ujino K, Takemoto Y,
Yamagishi H, Yoshiyama M, Yoshikawa J: Non-invasive assessment of
myocardial ischaemia using new real-time three-dimensional
dobutamine stress echocardiography: comparison with conventional
two-dimensional methods. Eur Heart J 2005, 26:1625-32.
Bombardini et al. Cardiovascular Ultrasound 2010, 8:48
http://www.cardiovascularultrasound.com/content/8/1/48
Page 21 of 22
70. Oh JK, Hatle L, Tajik AJ, Little WC: Diastolic heart failure can be diagnosed
by comprehensive two-dimensional and Doppler echocardiography. J
Am Coll Cardiol 2006, 47:500-6.
71. Sohn DW, Kim YJ, Kim HC, Chun HG, Park YB, Choi YS: Evaluation of left
ventricular diastolic function when mitral E and A waves are completely
fused: role of assessing mitral annulus velocity. J Am Soc Echocardiogr
1999, 12:203-8.
72. Ha JW, Oh JK, Pellikka PA, Ommen SR, Stussy VL, Bailey KR, Seward JB,
Tajik AJ: Diastolic stress echocardiography: a novel noninvasive
diagnostic test for diastolic dysfunction using supine bicycle exercise
Doppler echocardiography. J Am Soc Echocardiogr 2005, 18:63-8.
73. Burgess MI, Jenkins C, Sharman JE, Marwick TH: Diastolic stress
echocardiography: hemodynamic validation and clinical significance of
estimation of ventricular filling pressure with exercise. J Am Coll Cardiol
2006, 47:1891-900.
doi:10.1186/1476-7120-8-48
Cite this article as: Bombardini et al.: WEB downloadable software for
training in cardiovascular hemodynamics in the (3-D) stress echo lab.
Cardiovascular Ultrasound 2010 8:48.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bombardini et al. Cardiovascular Ultrasound 2010, 8:48
http://www.cardiovascularultrasound.com/content/8/1/48
Page 22 of 22
